Cutaneous T-Cell Lymphoma Therapy
New cutaneous t-cell lymphoma therapy research from University Hospital, Department of Dermatology discussed
Published in Blood Weekly, January 31st, 2008
Investigators publish new data in the report 'Maintenance therapy in cutaneous T-cell lymphoma: who, when, what.' According to recent research from Zurich, Switzerland, "The aim of current therapy for cutaneous T-cell lymphoma (CTCL) is to induce clinically meaningful remission, provide symptom relief, improve patient quality of life (QoL) and prolong disease-free and overall survival. A key research question is whether such remissions or minimal disease status can be maintained in the long term."
"There have been few formal studies of maintenance therapy in CTCL. Some skin-directed therapies such as total-skin electron-beam therapy and high-dose psoralen plus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-01-31)
More Articles from Blood Weekly
- Ischemia
An emerging candidate for protecting patients from liver injury after abdomen surgery - Obesity
Extreme obesity affects chances of kidney transplantation - Tissue Engineering
U of M researchers create beating heart in laboratory - Cancer
Investigators at Showa University have published new data on cancer - Cardiopulmonary Bypass
Studies from Brussels Free University yield new data on cardiopulmonary bypass - Depression
Reports outline depression research from L. Tuon and colleagues - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
